Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
88.40    -9.40 (-9.61%)
Bid:
89.30
Ask:
89.50
Spread: 0.20 (0.224%)
Market Cap: £144.93m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Director/PDMR Shareholding

3 Jan 2012 16:51

RNS Number : 9322U
Yule Catto & Co PLC
03 January 2012
 

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R(1).

 

(1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

 

(2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

 

(3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

 

(4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 

1. Name of the issuer

 

YULE CATTO & CO PLC

 

2. State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2R; (ii) a disclosure made in accordance with LR 9.8.6R(1); or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006)

 

(i)

 

3. Name of person discharging managerial responsibilities/director

 

DR ALEXANDER DOBBIE

 

4. State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

 

NOTIFICATION RELATES TO DR A A DOBBIE AND HIS WIFE - MRS M S DOBBIE

 

5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a non-beneficial interest

 

NOTIICATION IS IN RESPECT OF THE BENEFICAL HOLDINGS OF DR DOBBIE AND HIS WIFE.

 

6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares

 

ORDINARY SHARES OF 10P EACH

 

7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

 

TD DIRECT INVESTING NOMINEES (EUROPE) LIMITED

 

8. State the nature of the transaction

 

SALE AND PURCHASE OF SHARES

 

9. Number of shares, debentures or financial instruments relating to shares acquired

 

16,000 SHARES

 

10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

 

0.005%

 

11. Number of shares, debentures or financial instruments relating to shares disposed

 

16,000 SHARES

 

12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

 

0.005%

 

13. Price per share or value of transaction

 

16,000 SHARES SOLD BY DR A A DOBBIE AT £1.6414 PER SHARE

3,000 SHARES BOUGHT BY DR A A DOBBIE AT £1.6487 PER SHARE

13,000 SHARES BOUGHT BY MRS M S DOBBIE AT £1.6546 PER SHARE

 

14. Date and place of transaction

 

31 DECEMBER 2011

 

15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

 

TOTAL HOLDIG UNCHANGED AT 114,853 SHARES; 0.034% OF ISSUED SHARE CAPITAL

 

16. Date issuer informed of transaction

 

3 JANUARY 2012

 

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes 

17 Date of grant

 

 

18. Period during which or date on which it can be exercised

 

 

19. Total amount paid (if any) for grant of the option

 

 

20. Description of shares or debentures involved (class and number)

 

 

21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

 

 

22. Total number of shares or debentures over which options held following notification

 

 

23. Any additional information

 

 

24. Name of contact and telephone number for queries

 

RICHARD ATKINSON

TEL: 01279 459512

 

Name and signature of duly authorised officer of issuer responsible for making notification

 

RICHARD ATKINSON - COMPANY SECRETARY

 

Date of notification

3 JANUARY 2012

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBKNDQABKDADK
Date   Source Headline
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement
2nd Jan 20259:00 amRNSDirectorate Change
31st Oct 20247:00 amRNSTrading statement - Autumn 2024
17th Oct 20244:01 pmRNSHolding(s) in Company
14th Oct 20241:51 pmRNSHolding(s) in Company
27th Sep 202412:46 pmRNSHolding(s) in Company
19th Sep 20241:01 pmRNSHolding(s) in Company
13th Aug 20247:00 amRNSInterim results
18th Jul 202412:53 pmRNSChair succession and other board changes
17th May 20248:20 amRNSPost Stabilisation Notice
9th May 20242:29 pmRNSResults of AGM
9th May 20247:00 amRNSTrading Statement - Spring 2024
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.